{"nct_id":"NCT05489237","title":"First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-08-03","start_date_type":"ACTUAL","primary_completion_date":"2027-03-10","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11-03","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["GSK"]}